BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28534645)

  • 21. Morphine and myocardial ischaemia-reperfusion.
    Wu LN; Hu R; Yu JM
    Eur J Pharmacol; 2021 Jan; 891():173683. PubMed ID: 33121952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of myocardial ischaemia-reperfusion injury in patients with ST-segment elevation myocardial infarction: promise, disappointment, and hope.
    He J; Bellenger NG; Ludman AJ; Shore AC; Strain WD
    Rev Cardiovasc Med; 2022 Jan; 23(1):23. PubMed ID: 35092215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Myocardial Injury With Serum Procalcitonin Levels in Patients With ST-Elevation Myocardial Infarction.
    Reindl M; Tiller C; Holzknecht M; Lechner I; Henninger B; Mayr A; Brenner C; Klug G; Bauer A; Metzler B; Reinstadler SJ
    JAMA Netw Open; 2020 Jun; 3(6):e207030. PubMed ID: 32539151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy.
    Wang P; Hu Y; Yao D; Li Y
    Cell Physiol Biochem; 2018; 49(6):2163-2173. PubMed ID: 30286467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of HtrA2, a mitochondrial serine protease mediates apoptosis: current knowledge on HtrA2 mediated myocardial ischemia/reperfusion injury.
    Bhuiyan MS; Fukunaga K
    Cardiovasc Ther; 2008; 26(3):224-32. PubMed ID: 18786092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neprilysin levels are associated with myocardial stunning after ST-elevation myocardial infarction.
    Legallois D; Macquaire C; Hodzic A; Allouche S; El Khouakhi I; Manrique A; Milliez P; Saloux E; Beygui F
    BMC Cardiovasc Disord; 2020 Jul; 20(1):316. PubMed ID: 32615924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-Level Tragus Stimulation for the Treatment of Ischemia and Reperfusion Injury in Patients With ST-Segment Elevation Myocardial Infarction: A Proof-of-Concept Study.
    Yu L; Huang B; Po SS; Tan T; Wang M; Zhou L; Meng G; Yuan S; Zhou X; Li X; Wang Z; Wang S; Jiang H
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1511-1520. PubMed ID: 28797427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
    van Diepen S; Alemayehu WG; Zheng Y; Theroux P; Newby LK; Mahaffey KW; Granger CB; Armstrong PW
    J Thromb Thrombolysis; 2016 Oct; 42(3):376-85. PubMed ID: 27324144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serine protease HtrA2/Omi regulates adaptive mitochondrial reprogramming in the brain cortex after ischemia/reperfusion injury via UCP2-SIRT3-PGC1 axis.
    Meng H; Sun LK; Su J; Yan WY; Jin Y; Luo X; Jiang XR; Wang HL
    Hum Cell; 2022 Jan; 35(1):63-82. PubMed ID: 34807408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adiponectin and ischemia-reperfusion injury in ST segment elevation myocardial infarction.
    De Roeck L; Vandamme S; Everaert BR; Hoymans V; Haine S; Vandendriessche T; Bosmans J; Ronsyn MW; Miljoen H; Van Berendoncks A; De Meyer G; Vrints C; Claeys MJ
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):71-6. PubMed ID: 25722457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of ADAMTS13 in acute myocardial infarction: cause or consequence?
    Eerenberg ES; Teunissen PF; van den Born BJ; Meijers JC; Hollander MR; Jansen M; Tijssen R; Beliƫn JA; van de Ven PM; Aly MF; Kamp O; Niessen HW; Kamphuisen PW; Levi M; van Royen N
    Cardiovasc Res; 2016 Aug; 111(3):194-203. PubMed ID: 27174213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neprilysin levels at the acute phase of ST-elevation myocardial infarction.
    Bernelin H; Mewton N; Si-Mohamed S; Croisille P; Rioufol G; Bonnefoy-Cudraz E; Douek P; Dufay N; Amaz C; Jossan C; Ovize M; Bochaton T
    Clin Cardiol; 2019 Jan; 42(1):32-38. PubMed ID: 30284298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non-ST-elevation Myocardial Infarction.
    Blondheim DS; Kleiner-Shochat M; Asif A; Kazatsker M; Frimerman A; Abu-Fanne R; Neiman E; Barel M; Levy Y; Amsalem N; Shotan A; Meisel SR
    Am J Cardiol; 2018 Jun; 121(12):1449-1455. PubMed ID: 29699746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings.
    Campo G; Morciano G; Pavasini R; Bonora M; Sbano L; Biscaglia S; Bovolenta M; Pinotti M; Punzetti S; Rizzo P; Aquila G; Giorgi C; Ferrari R; Pinton P
    Int J Cardiol; 2016 Oct; 221():993-7. PubMed ID: 27441480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ischemic postconditioning during primary percutaneous coronary intervention for patients with ST-segment elevation myocardial infarction: A single-center cross-sectional study.
    Mukherjee P; Jain M
    Ann Card Anaesth; 2019; 22(4):347-352. PubMed ID: 31621667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower plasma protein C activity is associated with early myocardial necrosis and no-reflow phenomenon in patients with ST elevation myocardial infarction.
    Stankovic S; Obradovic S; Dzudovic B; Djenic N; Romanovic R; Jovic Z; Spasic M; Djuric O; Malovic D; Stavric M; Subota V
    Acta Cardiol; 2019 Aug; 74(4):331-339. PubMed ID: 30204553
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
    Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.